Related Experiment Video
Updated: Jun 29, 2025

11:36
Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
10.4K
Structural Elucidation and Prognostic Relevance of 297-11A-Sulfated Glycans in Ovarian Carcinoma
Daisuke Inoue1, Hitomi Hoshino2, Ya-Ying Chen3
1Department of Tumor Pathology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan; Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.
Summary
New ovarian cancer biomarkers are crucial due to poor prognosis. This study identifies 297-11A-sulfated glycans, linked to MUC16, as potential predictors of ovarian carcinoma recurrence and shorter survival.
Area of Science:
- Glycobiology
- Oncology
- Biomarker Discovery
Background:
- Ovarian carcinoma often presents at advanced stages with poor prognosis, necessitating novel prognostic biomarkers.
- Previous studies indicated keratan sulfate (KS) expression in ovarian cancer, but detailed structures and significance were unclear.
Purpose of the Study:
- To characterize 297-11A-sulfated glycans in ovarian carcinoma using the 297-11A antibody.
- To determine the structural features and core protein association of these glycans.
- To evaluate the prognostic value of 297-11A-sulfated glycans in ovarian cancer patients.
Main Methods:
- Immunohistochemical analysis of 98 ovarian carcinoma cases with 297-11A antibody and glycosidases.
- Mass spectrometry analysis of OVCAR-3 cells to deduce glycan structure.
- Western blot analysis to assess association with MUC16 (CA125).
Main Results:
- 297-11A-sulfated glycans were primarily found in serous and endometrioid ovarian carcinomas.
- Structurally, these are O-glycans with partially sialylated, Gal-6-O-sulfated N-acetyllactosamine (LacNAc) on MUC16.
- Expression of these glycans correlated with shorter progression-free survival.
Conclusions:
- 297-11A-sulfated glycans are O-glycans associated with MUC16 in ovarian carcinoma.
- These glycans are differentially expressed across ovarian carcinoma subtypes.
- 297-11A-sulfated glycan expression serves as a potential predictor for ovarian carcinoma recurrence.
More Related Videos
Related Concept Videos
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Protein Glycosylation
6.9K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.9K

